Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

rTMS-tACS Stimulation on Improving Cognitive Function in Bipolar Disorder

NCT: NCT05964777 · COMPLETED

NCT IDNCT05964777
StatusCOMPLETED
Start Date2023-07-01
Completion2024-08-03

Brief Summary

Based on the individualized positioning technology of diffusion tensor imaging (DTI), the purpose of this study is to explore a new stimulation target and protocol for the treatment of bipolar disorder in remission through the repetitive transcranial magnetic stimulation(rTMS) and transcranial alternating current stimulation(tACS)under neuronavigation,verify whether there is abnormal functional connectivity and structural connections between the dorsolateral prefrontal cortex (dlpfc) and the dorsal anterior cingulate gyrus (dacc) related to cognitive impairment in bipolar disorder in remission, which will contribute to further understand the relevant neural pathway and mechanism.

Frequently Asked Questions

What is rTMS-tACS Stimulation on Improving Cognitive Function in Bipolar Disorder?

rTMS-tACS Stimulation on Improving Cognitive Function in Bipolar Disorder is a clinical trial registered under NCT05964777. Current status: COMPLETED.

What is the status of NCT05964777?

The current status of NCT05964777 (rTMS-tACS Stimulation on Improving Cognitive Function in Bipolar Disorder) is: COMPLETED.

When did rTMS-tACS Stimulation on Improving Cognitive Function in Bipolar Disorder start?

rTMS-tACS Stimulation on Improving Cognitive Function in Bipolar Disorder started on 2023-07-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.